Skip to main content
Journal cover image

Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables.

Publication ,  Journal Article
Nichols, BS; Chelales, E; Wang, R; Schulman, A; Gallagher, J; Greenup, RA; Geradts, J; Harter, J; Marcom, PK; Wilke, LG; Ramanujam, N
Published in: J Biophotonics
October 2020

Use of genomic assays to determine distant recurrence risk in patients with early stage breast cancer has expanded and is now included in the American Joint Committee on Cancer staging manual. Algorithmic alternatives using standard clinical and pathology information may provide equivalent benefit in settings where genomic tests, such as OncotypeDx, are unavailable. We developed an artificial neural network (ANN) model to nonlinearly estimate risk of distant cancer recurrence. In addition to clinical and pathological variables, we enhanced our model using intraoperatively determined global mammographic breast density (MBD) and local breast density (LBD). LBD was measured with optical spectral imaging capable of sensing regional concentrations of tissue constituents. A cohort of 56 ER+ patients with an OncotypeDx score was evaluated. We demonstrated that combining MBD/LBD measurements with clinical and pathological variables improves distant recurrence risk prediction accuracy, with high correlation (r = 0.98) to the OncotypeDx recurrence score.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Biophotonics

DOI

EISSN

1864-0648

Publication Date

October 2020

Volume

13

Issue

10

Start / End Page

e201960235

Location

Germany

Related Subject Headings

  • Risk Assessment
  • Optoelectronics & Photonics
  • Neoplasm Staging
  • Neoplasm Recurrence, Local
  • Humans
  • Breast Neoplasms
  • 3404 Medicinal and biomolecular chemistry
  • 3401 Analytical chemistry
  • 1004 Medical Biotechnology
  • 0304 Medicinal and Biomolecular Chemistry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nichols, B. S., Chelales, E., Wang, R., Schulman, A., Gallagher, J., Greenup, R. A., … Ramanujam, N. (2020). Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables. J Biophotonics, 13(10), e201960235. https://doi.org/10.1002/jbio.201960235
Nichols, Brandon S., Erika Chelales, Roujia Wang, Amanda Schulman, Jennifer Gallagher, Rachel A. Greenup, Joseph Geradts, et al. “Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables.J Biophotonics 13, no. 10 (October 2020): e201960235. https://doi.org/10.1002/jbio.201960235.
Nichols BS, Chelales E, Wang R, Schulman A, Gallagher J, Greenup RA, et al. Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables. J Biophotonics. 2020 Oct;13(10):e201960235.
Nichols, Brandon S., et al. “Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables.J Biophotonics, vol. 13, no. 10, Oct. 2020, p. e201960235. Pubmed, doi:10.1002/jbio.201960235.
Nichols BS, Chelales E, Wang R, Schulman A, Gallagher J, Greenup RA, Geradts J, Harter J, Marcom PK, Wilke LG, Ramanujam N. Quantitative assessment of distant recurrence risk in early stage breast cancer using a nonlinear combination of pathological, clinical and imaging variables. J Biophotonics. 2020 Oct;13(10):e201960235.
Journal cover image

Published In

J Biophotonics

DOI

EISSN

1864-0648

Publication Date

October 2020

Volume

13

Issue

10

Start / End Page

e201960235

Location

Germany

Related Subject Headings

  • Risk Assessment
  • Optoelectronics & Photonics
  • Neoplasm Staging
  • Neoplasm Recurrence, Local
  • Humans
  • Breast Neoplasms
  • 3404 Medicinal and biomolecular chemistry
  • 3401 Analytical chemistry
  • 1004 Medical Biotechnology
  • 0304 Medicinal and Biomolecular Chemistry